Is it really duct carcinoma in situ?

Annals of Surgical Oncology

Volumn 8, Issue 8, 2001, Pages 617-619

  Cody III, H S ^a   Klauber DeMore, N ^a   Borgen, P I ^a   Van Zee, K J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INVASION; CANCER STAGING; CARCINOMA IN SITU; EDITORIAL; LYMPH NODE BIOPSY; METASTASIS; PROGNOSIS;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 0034847925     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.8.617     Document Type: Editorial

References (22)

1. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
2. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-17
3. Tamoxifen in the treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
4. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853
5. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)
6. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853
7. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy
8. Borderline epithelial lesions of the breast
9. Axillary lymph node dissection for intraductal breast carcinoma-is it indicated?
10. Clinical aspects of sentinel node biopsy
11. Sentinel node biopsy in duct carcinoma in situ patients
12. Lymphatic mapping and sentinel lymph node biopsy
13. Lymphatic mapping in the treatment of breast cancer
14. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers ≤1 centimeter (T1A-T1B)
15. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
16. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma
17. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
18. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
19. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
20. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast
21. Sentinel node biopsy for patients with DCIS: A dangerous and unwarranted direction
22. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: Results of a multi-institutional study